| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 14/02/2017 | 13:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/09/2016 | 15:06 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 06/09/2016 | 12:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 02/09/2016 | 00:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 30/08/2016 | 20:56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 30/08/2016 | 20:51 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 29/08/2016 | 22:18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 29/08/2016 | 22:12 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 29/08/2016 | 19:17 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 29/08/2016 | 13:58 | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Results of Tender Offer to Purchase All of the Outstanding Shares of Common Stoc... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 29/08/2016 | 12:17 | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 22/08/2016 | 23:51 | PR Newswire (US) | Chemical Financial Set to Join S&P MidCap 400; Supervalu, Shoe Carnival and Eagle Pharmaceuticals to Join S&P SmallCap 600 | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 17/08/2016 | 23:45 | GlobeNewswire Inc. | Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10 g due to presence of iron ... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 09/08/2016 | 15:25 | Business Wire | Nichi-Iko Pharmaceutical Co., Ltd. Announces Expiration of HSR Waiting Period for Proposed Acquisition of Sagent Pharmaceutic... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 05/08/2016 | 22:24 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 01/08/2016 | 15:55 | Business Wire | Shepard Vision, Inc., a Wholly-Owned Subsidiary of Nichi-Iko Pharmaceutical Co., Ltd, Commences All-Cash Tender Offer of $21.... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 01/08/2016 | 12:16 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 01/08/2016 | 12:12 | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 28/07/2016 | 15:12 | PR Newswire (US) | Sapiens Names Andre M. Boisvert Chairman of Sapiens DECISION Board of Directors | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 22/07/2016 | 17:48 | Business Wire | INVESTOR ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Sagent Pharmaceuticals... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 19/07/2016 | 20:02 | Business Wire | INVESTOR ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Sagent Pharmaceuticals, Inc. And Encourages... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 18/07/2016 | 18:55 | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Sagent Pharmaceuticals, Inc. ... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 18/07/2016 | 14:00 | GlobeNewswire Inc. | Sagent Pharmaceuticals Announces the Launch of Amikacin Sulfate Injection, USP | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 13/07/2016 | 23:15 | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning the Sale of Sagent Pharmaceuticals, Inc. to Ni... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 13/07/2016 | 01:20 | Dow Jones News | Teva Raises Guidance | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 12/07/2016 | 23:23 | PR Newswire (US) | SAGENT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Sagent Pharmaceuticals, Inc. (SGNT) Over the P... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 12/07/2016 | 23:09 | PR Newswire (US) | Sagent Pharmaceuticals, Inc. Acquisition May Not Be in the Best Interests of SGNT Shareholders | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 12/07/2016 | 22:14 | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 12/07/2016 | 18:40 | Business Wire | INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Into the Sale of Sagent Pharmaceuticals, Inc. to Nichi-Iko P... | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |
| 12/07/2016 | 17:07 | PR Newswire (US) | Ryan & Maniskas, LLP Announces Investigation of Sagent Pharmaceuticals, Inc. | NASDAQ:SGNT | Sagent Pharmaceuticals, Inc. |